Inventor · disambiguated record
Ryan Beal
Also filed as: BEAL RYAN · BEAL RYAN R
15 granted patents·21 pending applications·51 citations·filing 2015–2025
92Inventor score
Top patents by PatentIndex Score
36 records- 0196US10933088B2Method of administration and treatmentAMPERSAND BIOPHARMACEUTICALS INC·Filed 2020·Granted Mar 2, 2021·8 cites·20 claims
- 0295US11389472B2Method of administration and treatmentDYVE BIOSCIENCES INC·Filed 2021·Granted Jul 19, 2022·2 cites·20 claims
- 0395US11052152B2Transdermal carrierAMPERSAND BIOPHARMACEUTICALS INC·Filed 2020·Granted Jul 6, 2021·8 cites·10 claims
- 0495US10639326B2Method of administration and treatmentAMPERSAND BIOPHARMACEUTICALS INC·Filed 2019·Granted May 5, 2020·8 cites·11 claims
- 0595US10632146B2Method of administration and treatmentAMPERSAND BIOPHARMACEUTICALS INC·Filed 2019·Granted Apr 28, 2020·8 cites·10 claims
- 0693US11491225B2Transdermal carrierDYVE BIOSCIENCES INC·Filed 2021·Granted Nov 8, 2022·2 cites·19 claims
- 0792US2025195664A1Transdermal carrierDYVE BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0891US11357792B2Method of administration and treatmentDYVE BIOSCIENCES INC·Filed 2021·Granted Jun 14, 2022·1 cites·19 claims
- 0987US12310983B2Method of administration and treatmentDYVE BIOSCIENCES INC·Filed 2023·Granted May 27, 2025·0 cites·16 claims
- 1085US12070503B2Transdermal carrierDYVE BIOSCIENCES INC·Filed 2022·Granted Aug 27, 2024·0 cites·17 claims
- 1183US11026896B2Transdermal penetrant formulations containing cannabidiolAMPERSAND BIOPHARMACEUTICALS INC·Filed 2019·Granted Jun 8, 2021·7 cites·10 claims
- 1283US2025262239A1Method of administration and treatmentDYVE BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1382US10814003B2Transdermal carrierAMPERSAND BIOPHARMACEUTICALS INC·Filed 2018·Granted Oct 27, 2020·2 cites·3 claims
- 1481US10842758B1Transdermal penetrant formulations containing cannabidiolAMPERSAND BIOPHARMACEUTICALS INC·Filed 2019·Granted Nov 24, 2020·5 cites·16 claims
- 1580US11793830B2Method of administration and treatmentDYVE BIOSCIENCES INC·Filed 2021·Granted Oct 24, 2023·0 cites·19 claims
- 1680US11744853B2Method of administration and treatmentDYVE BIOSCIENCES INC·Filed 2021·Granted Sep 5, 2023·0 cites·20 claims
- 1777US11730756B2Method of administration and treatmentDYVE BIOSCIENCES INC·Filed 2021·Granted Aug 22, 2023·0 cites·20 claims
- 1871US2019083386A1Methods and formulations for transdermal administration of buffering agentsAMPERSAND BIOPHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1971US2019083527A1Method of administration and treatmentAMPERSAND BIOPHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2067US2024307412A1Methods for treating inflammatory pain and bone decalcificationDYVE BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2167US2024307295A1Methods for treating gout and bone decalcificationDYVE BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2265US2024226000A9Transdermal penetrant formulations for administration of medicamentsDYVE BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2363US2018271983A1Transdermal carrierINTELLECTUAL PROPERTY ASS LLC·Filed 2018·Application pending·0 cites
- 2461US2024390265A1Formulations for transdermal administration of active agentsDYVE BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2560US2023134922A1Topical delivery of buffering agents for prevention and treatment of viral infectionsDYVE BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2657US2023038462A1Transdermal penetrant formulations containing cannabidiolDYVE BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 2757US2016235851A1Methods and formulations for transdermal administrationINTELLECTUAL PROPERTY ASS LLC·Filed 2015·Application pending·0 cites
- 2856US2021268122A1Inhibition of spontaneous metastasis via protein inhibitors of cysteine proteasesDYVE BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 2955US2019134219A1Inhibition of spontaneous metastasis via protein inhibitors of cysteine proteasesAMPERSAND BIOPHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3055US2022323344A1Transdermal penetration by modulating epithelial junctionsDYVE BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 3154US2022305076A1Topical cyclosporine for treating psoriasis and other ailmentsDYVE BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 3252US2021386906A1Methods and formulations for transdermal administration of dermal contouring agentsDYVE BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 3351US2022105062A1Transdermal penetrant formulationsDYVE BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 3448US2021369769A1Management of risk of cation overload and electrolyte imbalance with topically applied buffersAMPERSAND BIOPHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3547US2021338613A1Formulations and methods for transdermal administration of ketonesDYVE BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 3640US2022031738A1Iron formulations for topical administration and methods of treatment of iron deficiencyDYVE BIOSCIENCES INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ryan Beal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →